---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-086393"
form_type: "8-K"
ticker: "QURE"
cik: "0001590560"
company_name: "uniQure N.V."
filed_at: "2023-08-01T23:59:59+00:00"
generated_at: "2026-06-12T18:14:46.138441+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# uniQure Q2 net loss $68.5M; cash $628.6M; AMT-130 shows preservation of function

## Summary
- Revenue $2.4M (up from $0.5M YoY); net loss $1.44/share vs $0.84 loss YoY.
- Cash $628.6M (excl. $100M milestone from HEMGENIX 1st US sale received July 2023).
- AMT-130 interim data: preserved clinical function vs natural history; both doses well-tolerated.
- Sale of HEMGENIX royalty for up to $400M; $375M upfront received.
- Appointed Walid Abi-Saab, M.D. as CMO and Jeannette Potts as CLO.

## SEC filing metadata
- accession: 0001104659-23-086393
- form_type: 8-K
- ticker: QURE
- cik: 0001590560
- company_name: uniQure N.V.
- filed_at: 2023-08-01T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1590560/000110465923086393/0001104659-23-086393-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1590560/000110465923086393/tm2322500d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-086393
- JSON: https://secwatch.observer/filing/0001104659-23-086393.json
- Plain text: https://secwatch.observer/filing/0001104659-23-086393.txt

## Key facts
- Earnings Releases
  uniQure N.V. reported financial results for the quarter ended June 30, 2023.
  - Period: the quarter ended June 30, 2023
  - Result: reported results
  source text: On August 1, 2023, uniQure N.V. (the “Company”) issued a press release announcing its financial results for the quarter ended June 30, 2023, and highlighting company progress.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1590560/000110465923086393/0001104659-23-086393-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.